The global Butterfly Needle Sets Market size was valued at USD 281.13 million in 2024 and is projected to grow from USD 304.46 million in 2025 to USD 576.19 million by 2033, registering a CAGR of 8.3% during the forecast period (2025–2033). The growing prevalence of chronic diseases, increasing blood transfusion procedures, and rising demand for safer and more precise venipuncture devices are driving the growth of the market worldwide.
Butterfly Needle Sets Gain Popularity in Modern Healthcare
Butterfly needle sets, also known as winged infusion sets or scalp vein sets, are widely used in hospitals, blood banks, and diagnostic centers for blood collection, intravenous hydration, and medication delivery. These devices are designed with flexible wings and thin needles, allowing healthcare professionals to access veins more accurately and comfortably.
Compared to traditional straight needles, butterfly needle sets offer better precision and reduced pain during insertion, making them ideal for pediatric, geriatric, oncology, and burn patients. Their increasing use in chemotherapy, blood transfusions, and IV therapies is contributing significantly to global market expansion.
Rising Chronic Diseases Fuel Market Growth
The increasing burden of chronic diseases such as cancer, cardiovascular disorders, hemophilia, and other bleeding disorders is a major factor driving the demand for butterfly needle sets.
According to the World Federation of Hemophilia, more than 210,000 people worldwide were diagnosed with hemophilia, while over 78,000 patients were identified with von Willebrand disease. These conditions require frequent blood collection and transfusion procedures, increasing the adoption of butterfly needles across healthcare facilities.
Additionally, the growing number of cancer patients globally has accelerated the use of intravenous therapies and chemotherapy treatments, further boosting the demand for butterfly needle sets. Healthcare providers prefer these devices because they reduce discomfort and improve patient experience during repeated blood access procedures.
Precision and Safety Features Support Market Expansion
Healthcare professionals increasingly favor butterfly needle sets because of their ease of use and improved safety features. Their shorter needle length and flexible tubing allow medical staff to insert them at shallow angles, reducing vein damage and minimizing patient discomfort.
Modern butterfly needle sets also include safety mechanisms such as slide-and-lock sheaths that automatically cover the needle after use. These innovations help lower the risk of accidental needlestick injuries among healthcare workers.
Studies published in Academic Emergency Medicine have also shown that butterfly needles reduce hemolysis rates during blood collection compared to intravenous catheter needles. These advantages continue to support their growing adoption in hospitals and blood banks worldwide.
Limited Product Innovation May Restrict Market Growth
Despite strong market demand, limited product innovation remains one of the major challenges for the butterfly needle sets market. Manufacturers have introduced fewer breakthrough advancements in recent years because current products already provide reduced needlestick injuries and efficient performance.
Healthcare facilities are also gradually adopting advanced blood collection technologies such as push-button blood collection systems. In addition, limited pipeline studies focused on neonatal and pediatric applications may restrict future innovation opportunities within the market.
Asia-Pacific Leads Global Butterfly Needle Sets Market
Asia-Pacific remains the dominant region in the global butterfly needle sets market and is expected to witness the fastest growth during the forecast period. Countries such as China, India, Japan, Australia, and South Korea are experiencing rising demand due to growing healthcare infrastructure, increasing blood donation activities, and expanding patient populations.
The region’s rising cases of thalassemia, cancer, and hemophilia are significantly contributing to market growth. Increasing healthcare spending and the presence of major manufacturers are also supporting regional expansion.
North America follows as the second-largest market due to the increasing prevalence of chronic diseases and strong healthcare infrastructure. The United States continues to lead the regional market with rising demand for blood collection procedures, clinical trials, and diagnostic testing.
Europe is also expected to witness substantial growth due to increasing awareness regarding needlestick injuries and growing adoption of safer blood collection systems in healthcare facilities.
Blood Transfusion Segment Holds Largest Market Share
Based on application, the blood transfusion segment dominates the global butterfly needle sets market. Butterfly needles are extensively used during blood transfusions because they provide efficient blood flow and improved patient comfort.
The venipuncture segment is also witnessing strong growth due to increasing diagnostic testing and blood sampling procedures across healthcare settings. Butterfly needles simplify blood collection from superficial veins and are especially preferred for newborns and elderly patients.
Hospitals Continue to Drive Product Demand
Hospitals account for the largest share of the butterfly needle sets market owing to increasing use of blood collection and intravenous procedures in critical care, oncology, cardiovascular surgeries, and emergency treatments.
Blood banks are another major end-user segment, supported by rising blood donation activities globally. Organizations such as the American National Red Cross report millions of blood donations annually, creating steady demand for safe and effective blood collection devices.
Key Companies Focus on Expansion and Partnerships
Leading companies operating in the global butterfly needle sets market are focusing on partnerships, acquisitions, and healthcare collaborations to strengthen their market presence.
Major players include B. Braun Melsungen AG, Becton, Dickinson and Company, Nipro Corporation, Cardinal Health Inc., Medline Industries, Inc., and Terumo Corporation.
In January 2023, Terumo Corporation partnered with Siemens Healthineers in India to improve cardiac care services and enhance physician training programs. In March 2022, B. Braun Melsungen AG acquired Intermedt Medizin & Technik GmbH to strengthen its healthcare product portfolio.
Market Outlook
The global butterfly needle sets market is expected to witness strong growth over the coming years due to rising chronic disease prevalence, increasing blood donation procedures, and growing focus on patient comfort and healthcare worker safety. Technological advancements and expanding healthcare access in emerging economies are likely to create new opportunities for manufacturers and healthcare providers worldwide.
Read Full butterfly needle sets market Report – https://straitsresearch.com/report/butterfly-needle-sets-market
